The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 4, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
AnemiaIron Deficiency AnemiaPerioperativeTransfusionCardiac Surgery
Interventions
DRUG

Iron sucrose, Human Erythropoietin Injection, Vitamin C

The participants were administered a combined iron supplementation regimen consisting of iron sucrose,Human Erythropoietin Injection, and vitamin C, three times throughout the preoperative week.

DRUG

Standard Medical Care

Standard Medical Care (SMC) for the treatment of IDA. SMC as determined by the Investigator for the treatment of iron deficiency anemia (IDA).

Trial Locations (1)

310000

RECRUITING

The Second Affiliated Hospital of Zhejiang University anesthesiology department, Hangzhou

All Listed Sponsors
collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

OTHER

collaborator

The Central Hospital of Lishui City

OTHER

collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Zhejiang Provincial People's Hospital

OTHER

collaborator

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

collaborator

Zhejiang University

OTHER

collaborator

Nanjing Hospital affiliated hospital of Nanjing medicine University

UNKNOWN

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER